The only meaningful comparison context is against the other agents in the class, covered in our Retatrutide vs Semaglutide vs Tirzepatide analysis, and the two entry points for the protocol itself are the 5 mg vial protocol for a gentle start and the 30 mg vial protocol for higher maintenance targets
Despite these promising findings, results across randomized clinical trials have been inconsistent
Delayed gastric emptying slower digestion prolongs satiety and decreases spikes in hunger-signalling hormones
Benefits should be balanced with risks such as hormonal disruption, side effects, lack of long-term safety data, and the risk of unregulated products, which require medical oversight and monitoring
A cannabis blog should not replace medical advice
FDA Safety Context for Compounded GLP-1 Medications in 2026 Quick Answer: Compounded GLP-1 medications are not FDA-approved and are not reviewed by FDA for safety, effectiveness, or quality before marketing